Low-density lipoprotein (LDL) cholesterol is a critical lipid subfract
ion because it is linked directly with the risk of coronary heart dise
ase (CHD). Current approaches to diagnosing and monitoring CHD emphasi
ze the significance of accurate, precise LDL values. Due to the inhere
nt complexity of measuring LDL by the reference method, ultracentrifug
ation, it usually is estimated by a calculation that uses measured val
ues for total cholesterol, high-density lipoprotein (HDL) cholesterol
and triglycerides. Calculated LDL (CLDL) results may be inaccurate, es
pecially if a patient triglyceride level is elevated, and it requires
a specimen from a patient who has fasted. New assays allow for the dir
ect measurement of LDL (DLDL) analogous to assays for HDL and do not r
equire the patient to fast. While CLDL typically compares well with ul
tracentrifugation and DLDL, it may provide a result that is different
in some instances; that difference may have clinical significance. A m
ethod comparison study of CLDL and DLDL resulted in the following line
ar regression equation: DLDL = 1.067 CLDL + 1.597, r = 0.974, n = 36.